Citizens Financial Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-754
Closed -$217K 834
2025
Q3
$217K Buy
+754
New +$202K ﹤0.01% 747
2023
Q2
Sell
-972
Closed -$191K 432
2023
Q1
$191K Buy
+972
New +$200K 0.01% 444
2022
Q3
Sell
-1,048
Closed -$211K 424
2022
Q2
$211K Buy
1,048
+6
+0.6% +$1.28K 0.01% 403
2022
Q1
$236K Buy
+1,042
New +$245K 0.01% 408
2020
Q3
Sell
-767
Closed -$110K 617
2020
Q2
$110K Sell
767
-174
-18% -$24.1K 0.01% 345
2020
Q1
$102K Hold
941
0.01% 332
2019
Q4
$136K Buy
941
+158
+20% +$22.8K 0.01% 298
2019
Q3
$113K Sell
783
-4
-0.5% -$584 0.01% 277
2019
Q2
$117K Buy
787
+4
+0.5% +$558 0.01% 272
2019
Q1
$103K Buy
783
+628
+405% +$77.4K 0.01% 283
2018
Q4
$17K Buy
+155
New +$20.8K ﹤0.01% 368
2017
Q4
Sell
-17
Closed -$2K 522
2017
Q3
$2K Buy
+17
New +$2.27K ﹤0.01% 495

Other funds holding LH

Citizens Financial Group's LH Position: Q4 2025 in Review

Citizens Financial Group sold out of Labcorp (LH) in Q4 2025, closing a stake of 754 shares — an estimated $217K sold.

Citizens Financial Group first reported a position in LH in Q3 2017 and held it in 12 quarters. The position peaked at $236K in Q1 2022. 1,027 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Citizens Financial Group reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Citizens Financial Group sold 754 Labcorp shares in Q4 2025, an estimated $217K.
  • Citizens Financial Group first reported a position in Labcorp in Q3 2017 and held it in 12 quarters.
  • Citizens Financial Group's Labcorp position peaked at $236K in Q1 2022.
  • 1,027 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Citizens Financial Group's 13F filing for Q4 2025, filed 30 Jan 2026.